Ostarine would be the closest SARM to staying authorized in medicine which is currently in period II clinical trials. Like SARMs generally speaking, MK-2866 targets androgen receptors over a selective foundation and avoids creating the varieties of harmful side effects associated with substances like testosterone, human growth hormone, or anabolic https://clayr776etj3.ouyawiki.com/user